Cherrell has had a distinguished clinical career in the detection and diagnosis of breast cancer. She is CEO and deputy chair of lifesciences venture capital fund QIC BioVentures, chair of Impedimed, and a non Executive Director of Tissue Therapies, Relevare and Xenome. She served as a member of the AusIndustry IR&D Board of Biologics Committee from 2001 -2006.
Dr Hirst has held non-executive directorships in financial services companies including Suncorp and MBF and is currently a Director of Medibank Private and the Avant Mutual Group. Dr Hirst was Chancellor of QUT from 1994-2004 and was elected to the Academy of Technology Sciences and Engineering in 2008. She has received three honorary doctorates, the award of Officer of the Order of Australia and a centenary medal in recognition of her work in breast cancer and education. Dr Hirst was Queenslander of the Year in 1995.
Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results
Dec 11, 2013 Hatchtech Receives SPA and Announces Patent Grants